National Institute for Health Research, United Kingdom
OrganisationROR
Trials
Collaborator, Phase 3, Recruiting, 1,200 people, 23 Jul 2026
Collaborator, Early phase 1, Status unknown, 60 people, 15 Oct 2024
Collaborator, Early phase 1, Status unknown, 60 people, 4 Oct 2024
Collaborator, Early phase 1, Completed, 68 people, 3 Oct 2024
Collaborator, Phase 3, Recruiting, 1,084 people, 21 Mar 2024
Collaborator, Phase 1, Withdrawn, 0 people, 21 Apr 2021
Collaborator, Phase 1, Completed, 21 people, 1 Dec 2020
Collaborator, Early phase 1, Completed, 30 people, 25 Nov 2020
Collaborator, Phase 4, Completed, 203 people, 7 Jul 2020
Collaborator, Phase 2, Status unknown, 17 people, 4 Jun 2020
Collaborator, Phase 3, Recruiting, 70,000 people, 11 May 2020
Collaborator, Phase 2, Status unknown, 200 people, 29 Nov 2019
Collaborator, Phase 3, Status unknown, 44 people, 3 May 2019
Collaborator, Phase 2, Completed, 58 people, 12 Feb 2019
Collaborator, Phase 4, Completed, 1 person, 9 Jan 2019
Collaborator, Phase 2, Completed, 25 people, 9 Nov 2018
Collaborator, Phase 4, Status unknown, 50 people, 24 Oct 2018
Collaborator, Phase 4, Completed, 1,151 people, 20 Feb 2018
Collaborator, Phase 2, Completed, 79 people, 24 Nov 2017
Collaborator, Phase 3, Completed, 123 people, 14 Jul 2016
Funded papers
6 Oct 2026
NIHR203308, 2 Oct 2026
Epitope placement tunes CSF tau biomarkers: Comparison of P-tau217 and BD-tau designs
UKDRI-1003, 22 Sept 2026
98_1074_03, 20 Sept 2026
17 Sept 2026
091/0212, NIHR207424, NIHR200922, 16 Sept 2026
A Thematic Narrative Review of Osteoarthritis Risk Factors Across the Female Life Course
11 Sept 2026
NIHR200174, 4 Sept 2026
Sources: api.crossref.org